Aminolevulinic acid hydrochloride, known as ALA HCl (Gleolan, NX Development Corp.) as an optical imaging agent indicated in patients with gliomas

Approved Drugs > Hematology/Oncology (Cancer) Approvals & Safety Notifications



FDA approved aminolevulinic acid hydrochloride, known as ALA HCl (Gleolan, NX Development Corp.) as an optical imaging agent indicated in patients with gliomas (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery.  June 6, 2017.  More Information: https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm279174.htm